Europe 4K medical imaging market was valued at $224.1 million in 2021 and will grow by 12.9% annually over 2021-2031 owing to the increasing demand for superior visualization quality in the medical sector, availability of technologically developed products with high-definition medical imaging, rising prevalence of chronic diseases, massive R&D investment, and the rising healthcare expenditure … Read more
North America 4K medical imaging market is projected to grow by 8.8% annually in the forecast period and reach $827.2 million by 2031 driven by the increasing demand for superior visualization quality in the medical sector, availability of technologically developed products with high-definition medical imaging, rising prevalence of chronic diseases, massive R&D investment, and the … Read more
Global 4K medical imaging market will reach $2,585.1 million by 2031, growing by 11.8% annually over 2021-2031, driven by the increasing demand for superior visualization quality in the medical sector, availability of technologically developed products with high-definition medical imaging, rising prevalence of chronic diseases, massive R&D investment, and the rising healthcare expenditure amid COVID-19 pandemic.Highlighted … Read more
Asia Pacific 4K medical imaging market will grow by 14.8% annually with a total addressable market cap of $4,372.4 million over 2022-2031 owing to the increasing demand for superior visualization quality in the medical sector, availability of technologically developed products with high-definition medical imaging, rising prevalence of chronic diseases, massive R&D investment, and the rising … Read more
Asia Pacific active pharmaceutical ingredients market will grow by 8.8% annually with a total addressable market cap of $691.3 billion over 2021-2028, driven by rising adoption of biologics in disease management, increasing regulatory approvals, patent expiration of major drugs, growing trend of outsourcing and increase in geriatric population.Highlighted with 92 tables and 68 figures, this … Read more
Europe active pharmaceutical ingredients market was valued at $49.52 billion in 2021 and will grow by 7.3% annually over 2021-2028, driven by rising adoption of biologics in disease management, increasing regulatory approvals, patent expiration of major drugs, growing trend of outsourcing and increase in geriatric population. Highlighted with 95 tables and 69 figures, this 193-page … Read more
North America active pharmaceutical ingredients market is projected to grow by 5.3% annually in the forecast period and reach $111.44 billion by 2028, driven by rising adoption of biologics in disease management, increasing regulatory approvals, patent expiration of major drugs, growing trend of outsourcing and increase in geriatric population. Highlighted with 86 tables and 68 … Read more
Global active pharmaceutical ingredients market will reach $334 billion by 2028, growing by 6.9% annually over 2021-2028, driven by rising adoption of biologics in disease management, increasing regulatory approvals, patent expiration of major drugs, growing trend of outsourcing and increase in geriatric population.Highlighted with 146 tables and 104 figures, this 254-page report “Global Active Pharmaceutical … Read more
Europe surgical robotics market accounted for $1,206.7 million in 2020 and will grow by 15.0% annually over 2020-2030 driven by a rapid adoption of surgical robotics for various types of operation and surgery procedures across the world. Surgeons, patients, hospitals and treatment facilities are expected to increasingly seek advanced robotic solutions for modern surgery treatments … Read more
Asia Pacific minimally invasive neurosurgical systems market will grow by 13.2% annually with a total addressable market cap of $2,269.1 million over 2021-2030 owing to the rising incidents of neurological disorders, benefits offered by minimally invasive neurosurgery, increasing R&D investments, and technological advancements in MIS and robotics-based surgeries.Highlighted with 37 tables and 53 figures, this … Read more